Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing Medical University, Nanjing, China. *These authors contributed equally.
✉ Corresponding author: Qiyun Tang, Department of Geriatric Gastroenterology, Neuroendocrine Tumor Center, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Institute of Neuroendocrine Tumor, Nanjing Medical University, NO. 300 Guangzhou Road, Nanjing, China. Email: tqy831comMore
Citation:
Chen J, Ye M, Bai J, Hu C, Lu F, Gu D, Yu P, Tang Q. Novel insights into the interplay between m6A modification and programmed cell death in cancer. Int J Biol Sci 2023; 19(6):1748-1763. doi:10.7150/ijbs.81000. https://www.ijbs.com/v19p1748.htm
N6-methyladenosine (m6A) methylation, the most prevalent and abundant RNA modification in eukaryotes, has recently become a hot research topic. Several studies have indicated that m6A modification is dysregulated during the progression of multiple diseases, especially in cancer development. Programmed cell death (PCD) is an active and orderly method of cell death in the development of organisms, including apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis. As the study of PCD has become increasingly profound, accumulating evidence has revealed the mutual regulation of m6A modification and PCD, and their interaction can further influence the sensitivity of cancer treatment. In this review, we summarize the recent advances in m6A modification and PCD in terms of their interplay and potential mechanisms, as well as cancer therapeutic resistance. Our study provides promising insights and future directions for the examination and treatment of cancers.
Chen, J., Ye, M., Bai, J., Hu, C., Lu, F., Gu, D., Yu, P., Tang, Q. (2023). Novel insights into the interplay between m6A modification and programmed cell death in cancer. International Journal of Biological Sciences, 19(6), 1748-1763. https://doi.org/10.7150/ijbs.81000.
ACS
Chen, J.; Ye, M.; Bai, J.; Hu, C.; Lu, F.; Gu, D.; Yu, P.; Tang, Q. Novel insights into the interplay between m6A modification and programmed cell death in cancer. Int. J. Biol. Sci. 2023, 19 (6), 1748-1763. DOI: 10.7150/ijbs.81000.
NLM
Chen J, Ye M, Bai J, Hu C, Lu F, Gu D, Yu P, Tang Q. Novel insights into the interplay between m6A modification and programmed cell death in cancer. Int J Biol Sci 2023; 19(6):1748-1763. doi:10.7150/ijbs.81000. https://www.ijbs.com/v19p1748.htm
CSE
Chen J, Ye M, Bai J, Hu C, Lu F, Gu D, Yu P, Tang Q. 2023. Novel insights into the interplay between m6A modification and programmed cell death in cancer. Int J Biol Sci. 19(6):1748-1763.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.